Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin Type A for Dry Eye
NCT02403219Phase 1Completed
- Sponsor
- Instituto de Oftalmología Fundación Conde de Valenciana
- Start
- May 2013
- Primary completion
- Feb 2014
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 1, randomised, double-blind trial of botulinum toxin type A in dry eye syndrome (DED) (2 arms), sponsored by Instituto de Oftalmología Fundación Conde de Valenciana. Primary endpoints: Symptoms of dry eye at 6 months, Symptoms of conjunctivitis at 6 months and 7 more. Started May 2013; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT02403219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02403219.